[ Price : $8.95]
An FDA clinical trial finds that daily use of cannabidiol at levels typically used by consumers can cause elevated liver enzymes i...[ Price : $8.95]
FDA accepts for priority review a Gamida Cell supplemental BLA for omidubicel and its use in severe aplastic anemia.[ Price : $8.95]
Vanda Pharmaceuticals urges FDA commissioner Marty Makary to reconsider a recent agency decision upholding approvals of two generi...[ Price : $8.95]
AdvaMed and other device stakeholders urge the Centers for Medicare & Medicaid Services to overhaul how it covers new device techn...[ Price : $8.95]
Boston Scientific recalls (Class 1) its Carotid Wallstent Monorail Endoprosthesis due to a manufacturing defect that created an in...[ Price : $8.95]
A new Form FDA-483 cites significant GMP issues at the plant that makes Regenerons Eylea HD (aflibercept), delaying review of two ...[ Price : $8.95]
FDA clears a Signos 510(k) for what the company says is the first over-the-counter glucose monitoring system designed specifically...[ Price : $8.95]
FDA is now publishing drug safety data on a daily basis, a shift the agency says will give the public faster access to information...